Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Locatelli MA"'
Autor:
Nicolò E; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy; Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, NY, USA., Gandini S; Molecular and Pharmaco-Epidemiology Unit, Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan, Italy., Giugliano F; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy., Uliano J; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy., D'Ecclesiis O; Molecular and Pharmaco-Epidemiology Unit, Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan, Italy., Morganti S; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ferraro E; Breast Cancer Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Trapani D; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy., Tarantino P; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Zagami P; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy., Boldrini L; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy., Caramella I; Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy., Carnevale Schianca A; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy., Cristofanilli M; Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, NY, USA., Locatelli MA; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy., Esposito A; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy., Belli C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy., Minchella I; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy., Criscitiello C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy., Marra A; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy., Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Aug; Vol. 207, pp. 114181. Date of Electronic Publication: 2024 Jun 17.
Autor:
Antonarelli G; Department of Oncology and Haemato-Oncology (DIPO), University of Milan, Milan, Italy; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, IRCCS, Milan, Italy., Taurelli Salimbeni B; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, IRCCS, Milan, Italy., Marra A; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, IRCCS, Milan, Italy., Esposito A; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, IRCCS, Milan, Italy., Locatelli MA; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, IRCCS, Milan, Italy., Trapani D; Department of Oncology and Haemato-Oncology (DIPO), University of Milan, Milan, Italy; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, IRCCS, Milan, Italy., Pescia C; Division of Pathology, European Institute of Oncology (IEO), IRCCS, Milan, Italy., Fusco N; Department of Oncology and Haemato-Oncology (DIPO), University of Milan, Milan, Italy; Division of Pathology, European Institute of Oncology (IEO), IRCCS, Milan, Italy., Curigliano G; Department of Oncology and Haemato-Oncology (DIPO), University of Milan, Milan, Italy; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, IRCCS, Milan, Italy., Criscitiello C; Department of Oncology and Haemato-Oncology (DIPO), University of Milan, Milan, Italy; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, IRCCS, Milan, Italy. Electronic address: carmen.criscitiello@ieo.it.
Publikováno v:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2023 Dec; Vol. 192, pp. 104148. Date of Electronic Publication: 2023 Oct 01.
Autor:
Locatelli MA; New Drugs Development Division, European Institute of Oncology, Milan, Italy., Curigliano G; New Drugs Development Division, European Institute of Oncology, Milan, Italy., Eniu A; Cancer Institute Ion Chiricuta, Cluj-Napoca, Romania.
Publikováno v:
Breast care (Basel, Switzerland) [Breast Care (Basel)] 2017 Jul; Vol. 12 (3), pp. 152-158. Date of Electronic Publication: 2017 Jun 27.
Autor:
Locatelli MA; Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy., Aftimos P; Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Dees EC; Department of Hematology and Oncology, University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., LoRusso PM; Medical Oncology, Karmanos Cancer Institute, Detroit, MI, USA.; Yale Cancer Center, New Haven, CT, USA., Pegram MD; Breast Cancer Research Program, Stanford Cancer Institute, Stanford, CA, USA., Awada A; Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Huang B; Pfizer Oncology, Groton, CT, USA., Cesari R; Pfizer Oncology, Milan, Italy., Jiang Y; Pfizer Oncology, San Diego, CA, USA., Shaik MN; Pfizer Oncology, San Diego, CA, USA., Kern KA; Pfizer Oncology, San Diego, CA, USA., Curigliano G; Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy.
Publikováno v:
Oncotarget [Oncotarget] 2017 Jan 10; Vol. 8 (2), pp. 2320-2328.
Autor:
Curtis Z; Oxitec Ltd, Milton Park, Abingdon, Oxfordshire, United Kingdom; Imperial College London, South Kensington, London, United Kingdom., Matzen K; Oxitec Ltd, Milton Park, Abingdon, Oxfordshire, United Kingdom., Neira Oviedo M; Oxitec Ltd, Milton Park, Abingdon, Oxfordshire, United Kingdom., Nimmo D; Oxitec Ltd, Milton Park, Abingdon, Oxfordshire, United Kingdom., Gray P; Oxitec Ltd, Milton Park, Abingdon, Oxfordshire, United Kingdom., Winskill P; Oxitec Ltd, Milton Park, Abingdon, Oxfordshire, United Kingdom; Imperial College London, South Kensington, London, United Kingdom., Locatelli MA; Chemistry Institute, Campinas University (UNICAMP), Campinas, São Paulo, Brazil; Redox Consultoria e Remediação Ambiental, Itu, Sao Palo, Brazil., Jardim WF; Chemistry Institute, Campinas University (UNICAMP), Campinas, São Paulo, Brazil; Redox Consultoria e Remediação Ambiental, Itu, Sao Palo, Brazil., Warner S; Oxitec Ltd, Milton Park, Abingdon, Oxfordshire, United Kingdom., Alphey L; Oxitec Ltd, Milton Park, Abingdon, Oxfordshire, United Kingdom; Department of Zoology, Oxford University, Oxford, United Kingdom., Beech C; Oxitec Ltd, Milton Park, Abingdon, Oxfordshire, United Kingdom.
Publikováno v:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2015 Aug 13; Vol. 9 (8), pp. e0003999. Date of Electronic Publication: 2015 Aug 13 (Print Publication: 2015).
Autor:
Curigliano G; Division of Experimental Therapeutics, Breast Health Program, Istituto Europeo di Oncologia, Italy. Electronic address: giuseppe.curigliano@ieo.it., Bagnardi V; Division of Epidemiology and Biostatistics, Istituto Europeo di Oncologia, Italy; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milano, Italy., Bertolini F; Laboratory Division of Hematology-Oncology, Italy., Alcalay M; Department of Experimental Oncology, Italy; University of Milano, School of Medicine, Milano, Italy., Locatelli MA; Division of Experimental Therapeutics, Breast Health Program, Istituto Europeo di Oncologia, Italy., Fumagalli L; Division of Experimental Therapeutics, Breast Health Program, Istituto Europeo di Oncologia, Italy., Rabascio C; Laboratory Division of Hematology-Oncology, Italy., Calleri A; Laboratory Division of Hematology-Oncology, Italy., Adamoli L; Division of Experimental Therapeutics, Breast Health Program, Istituto Europeo di Oncologia, Italy., Criscitiello C; Division of Experimental Therapeutics, Breast Health Program, Istituto Europeo di Oncologia, Italy., Viale G; Department of Pathology, Istituto Europeo di Oncologia, Italy; University of Milano, School of Medicine, Milano, Italy., Goldhirsch A; Division of Experimental Therapeutics, Breast Health Program, Istituto Europeo di Oncologia, Italy.
Publikováno v:
Breast (Edinburgh, Scotland) [Breast] 2015 Jun; Vol. 24 (3), pp. 263-71. Date of Electronic Publication: 2015 Mar 12.
Autor:
Gelao L; Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milan, Italy., Criscitiello C, Esposito A, De Laurentiis M, Fumagalli L, Locatelli MA, Minchella I, Santangelo M, De Placido S, Goldhirsch A, Curigliano G
Publikováno v:
Immunotherapy [Immunotherapy] 2014; Vol. 6 (3), pp. 349-60.
Autor:
Brollo J; Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Milan, Italy., Kneubil MC, Botteri E, Rotmensz N, Duso BA, Fumagalli L, Locatelli MA, Criscitiello C, Lohsiriwat V, Goldhirsch A, Leonardi MC, Orecchia R, Curigliano G
Publikováno v:
Breast (Edinburgh, Scotland) [Breast] 2013 Oct; Vol. 22 (5), pp. 856-62. Date of Electronic Publication: 2013 May 01.
Autor:
Pastorelli D; Istituto Oncologico Veneto, IRCCS, Padova, Italy., Locatelli MA, Melotti B, Pisano C, Turano S, Mellino U, Provinciali N, Marchetti P, Dazzi C, Berretta M, Giordano A, Lorusso V
Publikováno v:
Journal of chemotherapy (Florence, Italy) [J Chemother] 2013 Oct; Vol. 25 (5), pp. 309-17.
Autor:
Locatelli MA; Chemistry Institute, University of Campinas, POB 6154, Campinas, SP 13083-970, Brazil., Sodré FF, Jardim WF
Publikováno v:
Archives of environmental contamination and toxicology [Arch Environ Contam Toxicol] 2011 Apr; Vol. 60 (3), pp. 385-93. Date of Electronic Publication: 2010 Jun 10.